The latest closing stock price for ZyVersa Therapeutics as of November 22, 2024 is 1.13.
An investor who bought $1,000 worth of ZyVersa Therapeutics stock at the IPO in 2022 would have $-885 today, roughly -1 times their original investment - a -51.41% compound annual growth rate over 3 years.
The all-time high ZyVersa Therapeutics stock closing price was 22.50 on December 12, 2022.
The ZyVersa Therapeutics 52-week high stock price is 6.70, which is 492.9% above the current share price.
The ZyVersa Therapeutics 52-week low stock price is 0.05, which is 95.6% below the current share price.
The average ZyVersa Therapeutics stock price for the last 52 weeks is 2.26.
An investor who bought $1,000 worth of ZyVersa Therapeutics stock at the IPO in 2022 would have $-885 today, roughly -1 times their original investment - a -51.41% compound annual growth rate over 3 years.
The all-time high ZyVersa Therapeutics stock closing price was 22.50 on December 12, 2022.
The ZyVersa Therapeutics 52-week high stock price is 6.70, which is 492.9% above the current share price.
The ZyVersa Therapeutics 52-week low stock price is 0.05, which is 95.6% below the current share price.
The average ZyVersa Therapeutics stock price for the last 52 weeks is 2.26.